Evidence map›Paper›PMID 42509232›Full record

ArticleBlood cancer journal2026

Pre-transplant molecular international prognostic scoring system score reduction is not associated with improved outcomes in myelodysplastic syndromes.

Masataka Sakashita, Junya Kanda, Keiichiro Hattori, Nobuhiro Hiramoto, Nobuhiro Kanemura, Senji Kasahara, Mitsumasa Watanabe, Satoshi Yoshihara, Michiko Ichii, Nobuo Sezaki and 10 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Masataka SakashitaDepartment of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Junya KandaDepartment of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-6704-3633
Keiichiro HattoriDepartment of Hematology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Nobuhiro HiramotoDepartment of Hematology, Kobe City Medical Center General Hospital, Hyogo, Japan.ORCID http://orcid.org/0000-0002-0472-6680
Nobuhiro KanemuraDepartment of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.ORCID http://orcid.org/0000-0001-8449-9918
Senji KasaharaDepartment of Hematology, Gifu Municipal Hospital, Gifu, Japan.
Mitsumasa WatanabeDepartment of Hematology, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan.ORCID http://orcid.org/0000-0003-4889-7999
Satoshi YoshiharaDepartment of Hematology, Hyogo Medical University Hospital, Hyogo, Japan.ORCID http://orcid.org/0000-0002-8537-2422
Michiko IchiiDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Nobuo SezakiDepartment of Hematology, Chugoku Central Hospital, Hiroshima, Japan.
Masaaki TsujiDepartment of Hematology and Immunology, Japanese Red Cross Otsu Hospital, Otsu, Japan.
Takeshi MaedaDepartment of Hematology/Oncology, Kurashiki Central Hospital, Kurashiki, Japan.ORCID http://orcid.org/0009-0009-4059-1777
Ko SasakiDepartment of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
Toshiyuki KitanoDepartment of Hematology, Medical Research Institute Kitano Hospital, Osaka, Japan.
Yasuko MiyaharaDepartment of Hematology, Kyoto City Hospital, Kyoto, Japan.
Tadakazu KondoDepartment of Hematology, Kobe City Medical Center General Hospital, Hyogo, Japan.ORCID http://orcid.org/0000-0002-8959-6271
Mamiko Sakata-YanagimotoDepartment of Hematology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.ORCID http://orcid.org/0000-0001-7310-8045
Akifumi Takaori-KondoDepartment of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0001-7678-4284
Seishi OgawaDepartment of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-7778-5374
Yasuhito NannyaDepartment of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. ynanya@ims.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0002-6526-0992

Funding

Japan Agency for Medical Research and Development (AMED) 24ck0106875h0002MEXT | Japan Society for the Promotion of Science (JSPS) 18H02836MEXT | Japan Society for the Promotion of Science (JSPS) 19H05656MEXT | Japan Society for the Promotion of Science (JSPS) 24H00009
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42509232
PMCPMC13408187

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.